about
Identification of thioredoxin glutathione reductase inhibitors that kill cestode and trematode parasitesFood-borne trematodiasesRepurposing drugs for the treatment and control of helminth infectionsTranscriptomic Study on Ovine Immune Responses to Fasciola hepatica InfectionStimulating Neoblast-Like Cell Proliferation in Juvenile Fasciola hepatica Supports Growth and Progression towards the Adult Phenotype In VitroPhysiological and morphological effects of genistein against the liver fluke, Fasciola hepaticaDevelopment of functional genomic tools in trematodes: RNA interference and luciferase reporter gene activity in Fasciola hepaticaEfficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trialsThe Sigma class glutathione transferase from the liver fluke Fasciola hepaticaFascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanideInsights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico ApproachesTegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycansFasciolosis in South America: epidemiology and control challenges.The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution.Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepaticaTowards delineating functions within the fasciola secreted cathepsin l protease family by integrating in vivo based sub-proteomics and phylogenetics.RNAi dynamics in Juvenile Fasciola spp. Liver flukes reveals the persistence of gene silencing in vitro.Fasciola hepatica is associated with the failure to detect bovine tuberculosis in dairy cattle.UDP-galactose 4'-epimerase from the liver fluke, Fasciola hepatica: biochemical characterization of the enzyme and identification of inhibitors.Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay.Anthelmintic Potential of Thymoquinone and Curcumin on Fasciola gigantica.Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasitesCalmodulin disruption impacts growth and motility in juvenile liver fluke.Pipeline for the identification and classification of ion channels in parasitic flatwormsXenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths.Complete mitochondrial genomes of the 'intermediate form' of Fasciola and Fasciola gigantica, and their comparison with F. hepatica.The biological significance of methionine sulfoxide stereochemistry.Anthelmintic metabolism in parasitic helminths: proteomic insights.Characterisation of a novel panel of polymorphic microsatellite loci for the liver fluke, Fasciola hepatica, using a next generation sequencing approach.FhCaBP2: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.In vitro ovicidal activity of Peganum harmala seeds extract on the eggs of Fasciola hepatica.Network Analysis of the Systemic Response to Fasciola hepatica Infection in Sheep Reveals Changes in Fibrosis, Apoptosis, Toll-Like Receptors 3/4, and B Cell Function.Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheepComparative biochemical analysis of three members of the Schistosoma mansoni TAL family: Differences in ion and drug binding properties.Selective reduction of methylsulfinyl-containing compounds by mammalian MsrA suggests a strategy for improved drug efficacyFhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.Pochonia chlamydosporia in the biological control of Fasciola hepatica in cattle in Southeastern Brazil.The metabolism of flubendazole and the activities of selected biotransformation enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics.
P2860
Q21560994-1D796F11-066F-4C35-8647-A3CC9FEE3382Q24650873-A1179594-6652-4F3F-862E-1183497030B9Q26823355-1E1A50F3-EEF1-47D1-94E1-C81F6581343DQ27303435-07DFB31F-EC69-473F-80C6-6397BCEB6820Q27303470-2B46556F-E902-40F0-8B2E-4920EF249688Q28292996-8CF7F39E-56CE-4E0A-AC58-450E09D69401Q28473071-157B3E0D-2CF0-4892-BE3B-D1873EF1363EQ28476800-CF1A71A6-8C85-44F9-A360-4B09810BC0B1Q28483983-61695869-B710-4851-AE46-2A973D239EA8Q28535341-8CB754A2-2F66-4950-A8C6-11694CF2FE0FQ28547256-469BC5B7-5171-49AC-BB4C-F6AFBC24977CQ28551767-EE500AD8-C53A-42DA-A908-67DBC7292BF1Q30245533-8B704F39-A5B9-4560-8362-0B2529BA0134Q30936124-F6F9313A-BD5F-41BB-B24B-FA3DBC27B00EQ31080479-54334EDD-CCF5-49C3-983C-2233951A1A30Q33765735-564BDD54-66B7-42D0-AE53-C95D3ED73376Q33796481-43F079DC-DECB-4D20-BD01-87E10664CA0DQ34257247-7F006DC1-934A-48EA-A70D-54A714AB672DQ34276631-160C3AB6-66D2-4279-B2EF-F440909AD448Q35225231-668580B3-EE6C-4588-A2C6-5090A7975CE7Q35757853-4D568031-1C73-4A6D-AD9E-ED974C9B415AQ36267982-D5C2B77D-2A90-4B06-9AA0-4995ADC214D1Q36319768-90DB8F83-6D08-4ED6-8C2F-8E314254E62CQ36444217-2090157B-A3E2-4965-9293-BE2D79EF4879Q36513985-8834E466-ACBB-4171-BEB0-73CE5C882DC8Q36694802-3C08D2B3-C2D6-4450-8C33-601E5EE80BF8Q37514335-87E06F1A-C3C2-405C-B93A-D50FECABB817Q37720209-BDC5C7EE-B98C-452A-8DB3-C5B9C3525630Q37809313-7C65F38F-A644-4EC3-8190-B4062F113F62Q38024902-5523FF59-B4BE-4D6E-B3A5-DC988FC40C9EQ38958762-0E7315D2-A02F-4599-B312-5CC34A3731C0Q39521198-AE623822-4EB7-46B6-9347-BCF633EF2297Q40171999-7E5DBBA9-C20C-447E-983F-C1949CE2D230Q40219501-79E2027F-91D2-4958-B3BF-59CA31C22E2FQ41436763-6B56193B-8A62-4C54-862C-C5E9FF9DFE50Q41758770-2492241F-D8C3-4D31-8D88-979E3EE8B191Q42570124-99A2C996-DB02-4D76-9201-4BC81800CDD5Q43458659-2A00F59C-EFD2-4FFC-917A-E868CF99002EQ43458769-D2E55C11-152C-49BB-BEC8-E138DA2AFDFDQ45357919-3BBA3BDE-BF5F-4EAF-A4EA-EE023B98E069
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Understanding triclabendazole resistance.
@ast
Understanding triclabendazole resistance.
@en
type
label
Understanding triclabendazole resistance.
@ast
Understanding triclabendazole resistance.
@en
prefLabel
Understanding triclabendazole resistance.
@ast
Understanding triclabendazole resistance.
@en
P2093
P1476
Understanding triclabendazole resistance.
@en
P2093
A Trudgett
G P Brennan
I Fairweather
P304
P356
10.1016/J.YEXMP.2007.01.009
P577
2007-02-15T00:00:00Z